Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Dividends Paid - Common (2020 - 2025)

Pharma-Bio Serv (PBSV) has disclosed Dividends Paid - Common for 6 consecutive years, with -$1.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Dividends Paid - Common changed N/A year-over-year to -$1.7 million, compared with a TTM value of $3.4 million through Apr 2025, changed 0.07%, and an annual FY2025 reading of $1.7 million, changed 0.13% over the prior year.
  • Dividends Paid - Common was -$1.7 million for Q3 2025 at Pharma-Bio Serv, down from $1.7 million in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $1.7 million in Q2 2021 and bottomed at -$1.7 million in Q3 2025.
  • Average Dividends Paid - Common over 4 years is $1.2 million, with a median of $1.7 million recorded in 2024.
  • The sharpest move saw Dividends Paid - Common fell 0.18% in 2022, then dropped 0.13% in 2025.
  • Year by year, Dividends Paid - Common stood at $1.7 million in 2021, then dropped by 0.18% to $1.7 million in 2022, then fell by 0.11% to $1.7 million in 2024, then plummeted by 199.87% to -$1.7 million in 2025.
  • Business Quant data shows Dividends Paid - Common for PBSV at -$1.7 million in Q3 2025, $1.7 million in Q2 2025, and $1.7 million in Q2 2024.